Homocysteine and cardiovascular disease

Annual Review of Medicine

Volumn 49, Issue , 1998, Pages 31-62

  Refsum, H ^a   Ueland, P M ^a   Nygard O ^a   Vollset, S E ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Folic acid; Homocysteine; Vascular disease; Vitamin B12; Vitamin B6

Indexed keywords

ACETYLCYSTEINE; AMINOTHIOL; ANTICONVULSIVE AGENT; BETAINE; COLESTYRAMINE; CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; HOMOCYSTEINE; LEVODOPA; METHIONINE; METHOTREXATE; NICOTINIC ACID; NITROUS OXIDE; PENICILLAMINE; PYRIDOXINE; TAMOXIFEN;

AGE; AMINO ACID BLOOD LEVEL; ARTERY THROMBOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL GENETICS; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; GENDER; GENETIC RISK; HEALTH BEHAVIOR; HEALTH ECONOMICS; HEART PROTECTION; HOMOCYSTINURIA; HORMONAL THERAPY; HYPERHOMOCYSTEINEMIA; KIDNEY FUNCTION; LIFESTYLE; LOADING TEST; MOLECULAR GENETICS; MORTALITY; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; VEIN THROMBOSIS;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FORECASTING; HOMOCYSTEINE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; SAFETY; THROMBOEMBOLISM; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0031958860     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.49.1.31     Document Type: Review

References (14)

1. Allen RH, Stabler SP, Savage DG, et al. 1994. Metabolic abnormalities in cobalamin (vitamin-B12) and folate deficiency. FASEB J. 7:1344-53
2. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, et al. 1992. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet 339:1122-23
3. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neuraltube defects? Metabolism 43:1475-80
4. Spillmann M, Fava M. 1996. S-adenosylmethionine (ademetionine) in psychiatric disorders: historical perspective and current status. Cns. Drugs 6:416-25
5. Smythies JR, Gottfries CG, Regland B. 1997. Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review. Biol. Psych. 41:230-33
6. Riggs KM, Spiro A, Tucker K, et al. 1996. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 63:306-14
7. Joosten E, Lesaffre E, Riezler R, et al. 1997. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J. Gerontol. A. Biol. Sci. Med. Sci. 52(2):M76-79
8. Ueland PM, Refsum H. 1989. Plasma homocysteine, a risk factor for vascular dis-ease: plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 114:473-501
9. Ueland PM, Refsura H, Brattström L. 1992. Plasma homocysteine and cardiovascular disease. In Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, ed. RB Francis Jr, pp. 183-236. New York: Dekker
10. Boushey CJ, Beresford SAA, Omenn GS, et al. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274:1049-57
11. Finkelstein JD. 1990. Methionine metabolism in mammals. J. Nutr. Biochem. 1:228-37
12. Storch KJ, Wagne DA, Burke JF, et al. 1990. [1-13C; methyl-2H3]Methionine kinetics in humans: methionine conservation and cystine sparing. Am. J. Physiol. 258:E790-98
13. Bates CJ, Fuller NJ. 1986. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. Br. J. Nutr. 55:455-64
14. Engbersen AMT, Franken DG, Boers GHJ, et al. 1995. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet. 56:142-50